Resources for you and your patients

Whether you need prior authorization (PA) how-to's and templates, telemedicine guidance,
or tools for your patients, we've got you covered. Check out the helpful resources below.

PA resources

We're here to help simplify the PA process.

Templates

Use the templates below to streamline and save time.

letter of medical necessity template
Letter of medical necessity template

A template to help simplify writing a letter of medical necessity.

letter of appeal template
Letter of appeal template

A template to help simplify writing a letter of appeal.

Guides

Here are some helpful guides in case you have questions or get stuck.

how-to guide for letter of medical necessity
Letter of medical necessity how-to guide

A guide to help you write a letter of medical necessity.

how-to practice guide for letter of appeal
Letter of appeal how-to guide

A practice guide to help you write a letter of appeal.

prior and reauthorization worksheet
Prior and reauthorization worksheet

A tool to help you prepare your PA requests for appropriate patients by listing potential criteria that your patients may need to meet for the health plan to approve initial or continued use of Nurtec ODT.

Treating migraine via telemedicine

Telemedicine resources

Help your patients make the most out of their virtual care visit.

treating migraine via telemedicine

Get tips for prescribing Nurtec ODT via telemedicine (including prescribing electronically and setting favorites).

Migraine management patient questionnaire

Patient resources

Ensure your patients have all the information and support they need.

migraine questionnaire tear pad

A questionnaire that can help you and your patients evaluate whether their current migraine management is working for them.

< Previous Page

Savings & Support

Important Safety Information

Contraindications: Hypersensitivity to Nurtec ODT or any of its components.

Warnings and Precautions: If a serious hypersensitivity reaction occurs, discontinue Nurtec ODT and initiate appropriate therapy. Serious hypersensitivity reactions have included dyspnea and rash, and can occur days after administration.

Adverse Reactions: The most common adverse reaction was nausea (2% in patients who received Nurtec ODT compared to 0.4% in patients who received placebo). Hypersensitivity, including dyspnea and rash, occurred in less than 1% of patients treated with Nurtec ODT.

Drug Interactions: Avoid concomitant administration of Nurtec ODT with strong inhibitors of CYP3A4, strong or moderate inducers of CYP3A or inhibitors of P‑gp or BCRP. Avoid another dose of Nurtec ODT within 48 hours when it is administered with moderate inhibitors of CYP3A4.

Use in Specific Populations: Pregnant/breast feeding: It is not known if Nurtec ODT can harm an unborn baby or if it passes into breast milk. Hepatic impairment: Avoid use of Nurtec ODT in persons with severe hepatic impairment. Renal impairment: Avoid use in patients with end-stage renal disease.

Indication

Nurtec ODT is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use
Nurtec ODT is not indicated for the preventive treatment of migraine.

Please click here for full Prescribing Information.